Literature DB >> 1430592

Severe acute myocardial infarction during a staphylococcal septicemia with meningoencephalitis. A possible contraindication to thrombolytic treatment.

C A Reynard1, P Calain, G P Pizzolato, J C Chevrolet.   

Abstract

We report the first case of lethal intracranial haemorrhage complicating a treatment by rt-PA in a patient presenting with a simultaneous staphylococcal septicemia with meningoencephalitis and an acute myocardial infarction with cardiogenic shock. The presence of microvascular lesions in the central nervous system seems to be important risk factor for intracranial haemorrhage and we recommend extreme caution in the use of thrombolytic treatment in septicemic patients with acute myocardial infarction, particularly when neurological symptoms are present.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1430592     DOI： 10.1007/bf01709842

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


  13 in total

1.  Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

Authors:  R G Wilcox; G von der Lippe; C G Olsson; G Jensen; A M Skene; J R Hampton
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

2.  Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis.

Authors:  C M O'Connor; R M Califf; E W Massey; D B Mark; D J Kereiakes; R J Candela; C Abbottsmith; B George; R S Stack; L Aronson
Journal:  J Am Coll Cardiol       Date:  1990-09       Impact factor: 24.094

Review 3.  Bacterial endocarditis presenting as acute myocardial infarction: a cautionary note for the era of reperfusion.

Authors:  C A Herzog; T D Henry; S D Zimmer
Journal:  Am J Med       Date:  1991-03       Impact factor: 4.965

4.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

5.  Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance.

Authors:  A J Nahmias; R J Whitley; A N Visintine; Y Takei; C A Alford
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

6.  Staphylococcus aureus bacteremia. Current clinical patterns.

Authors:  C M Nolan; H N Beaty
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

7.  Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.

Authors:  J M Gore; M Sloan; T R Price; A M Randall; E Bovill; D Collen; S Forman; G L Knatterud; G Sopko; M L Terrin
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

8.  Staphylococcus aureus meningitis: a broad-based epidemiologic study.

Authors:  L S Schlesinger; S C Ross; D R Schaberg
Journal:  Medicine (Baltimore)       Date:  1987-03       Impact factor: 1.889

9.  In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.

Authors: 
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321

10.  Myocardial infarction and stroke.

Authors:  M S Komrad; C E Coffey; K S Coffey; R McKinnis; E W Massey; R M Califf
Journal:  Neurology       Date:  1984-11       Impact factor: 9.910
View more
  1 in total

Review 1.  The Role of Blood Viscosity in Infectious Diseases.

Authors:  Gregory D Sloop; Quirijn De Mast; Gheorghe Pop; Joseph J Weidman; John A St Cyr
Journal:  Cureus       Date:  2020-02-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.